ASGCT 2026
New Gene Editing Capabilities From Discovery to Delivery
See How They Can Accelerate Your Programs
ElevateBio is delivering 10 presentations at the 29th Annual ASGCT Meeting – showcasing new gene editing modalities, AI-powered protein discovery, proprietary non-viral delivery, and more – that together reflect the breadth and integration of our genetic medicine platform. These capabilities are available to partners through flexible engagement models designed to increase the probability of clinical success.
PLATFORM HIGHLIGHTS
Discover, Edit, & Deliver
From AI-powered discovery to clinical-ready delivery, these capabilities are designed to de-risk your program at every stage.
New Modalities: Large Gene Insertion & Epigenetic Editing
Targeted large gene insertion and epigenetic editing join ElevateBio’s nuclease, base, and reverse transcriptase (RT) editing technologies — giving partners access to five editing modalities to match the right approach to each disease target.
- Large gene insertion enables precise placement of full-length therapeutic genes at defined genomic sites.
- Epigenetic editing enables precise control of gene expression without altering the underlying DNA sequence.
AI-Powered Discovery
Generative AI and protein language models accelerate the discovery and design of novel editing proteins, compressing the path from target selection to lead identification.
Non-Viral Delivery
Our proprietary LNP platform enables in vivo delivery of gene editing systems to tissues beyond the liver, potentially expanding the therapeutic reach of editing approaches available to partners.
GENE EDITING TOOLS & DISCOVERY SERVICES
Put These Capabilities to Work on Your Programs
The same platform behind our ASGCT presentations is available to your team, with visibility, transparency, and a straightforward path to clinical and commercial use backed by a robust IP portfolio.
Rapid Proof of Concept
Up to 3 gene editors for your target in under 6 months.
Clinical Candidate Optimization
Refine potency and specificity to maximize the likelihood of clinical success.
Build Your Pipeline
A full R&D collaboration allows you to pursue multiple targets in parallel with access to our entire editing toolbox.
ElevateBio Presentations at ASGCT
Abstracts are available on the ASGCT website. PDFs will be available for download following each presentation.
New Modalities
// May 14, 2026 at 8:45 a.m. ET. | Oral Presentation
Identification of novel, high-efficiency large serine recombinases and retrotransposases to enable targeted gene insertion
Session: Genome editing II
Location: MCEC Room 210ABC (Level 2)
// May 12, 2026 at 5:00 p.m. ET. | Poster
Versatile and robust epigenetic modulation platform for programmable gene activation and repression
AI-Powered Discovery
// May 13, 2026 at 5:00 p.m. ET. | Poster
Leveraging generative AI to design novel, functional deaminases for adenine base editing
// May 12, 2026 at 5:00 p.m. ET. | Poster
Active learning-guided optimization of large gene insertion effectors in mammalian cells
Non-Viral Delivery
// May 14, 2026 at 9:00 a.m. ET. | Oral Presentation
Iterative Engineering and Optimization Strategies for Maximizing LNP-mediated Gene Editing in the Liver
Session: Genome editing II
Location: MCEC Room 210ABC (Level 2)
// May 14, 2026 at 5:00 p.m. ET. | Poster
Engineering hepatocyte-targeted LNPs for RNA and DNA delivery to primary human T cells
Analytical & Sequencing
// May 14, 2026 at 5:00 p.m. ET. | Poster
Sequencing-based analytics offer potential for rapid sterility and adventitious agent testing
Additional Platform Presentations
// May 12, 2026 at 5:00 p.m. ET. | Poster
Leveraging protein and gRNA engineering of diverse CRISPR systems to optimize adenosine base editor activity for correction of a causative monogenic disease mutation
// May 12, 2026 at 5:00 p.m. ET. | Poster
Comprehensive off-target assessment strategies for CRISPR-based genome editing therapeutics: integrating biochemical, bioinformatic, and unbiased approaches
// May 14, 2026 at 5:00 p.m. ET. | Poster
Harnessing a diverse collection of CRISPR-associated RNA-guided nuclease and novel reverse transcriptases for precise gene editing
Work With Us
The capabilities behind our ASGCT presentations are available to partners year-round. Whether you’re exploring a proof of concept or building a full pipeline collaboration, let’s talk about what’s possible for your programs.
Attending ASGCT 2026?
Visit us at booth #1239 in Boston, May 11-15.
// Work with us
